Genocea names Katrine Bosley as chairman; EU defends plan to handle Syrian polio threat;

> Genocea Biosciences has named Katrine Bosley as chairman of its board of directors. News

> The European Centre for Disease Prevention and Control has responded to concerns about its handling of the Syrian polio threat. Letter

> Experts have warned that the U.S. lacks the surge capacity to handle a pandemic. Feature

> Roche ($RHHBY) has strengthened its cancer vaccine pipeline through a deal with immatics. Article

> Bavarian Nordic has completed its delivery of 20 million smallpox vaccines to the U.S. stockpile. Item

> The resurgence of the Welsh measles outbreak has prompted fresh calls for a vaccination campaign. Piece

> A nurse who described an unvaccinated child as a 'loser' has kept her job. News

> The opening of South Africa-based Litha Healthcare's vaccine plant is being held up by regulatory red tape. Article

> Inovio Pharmaceuticals ($INO) has presented positive preclinical data on its MERS-CoV vaccine. Item

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.